Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Express Scripts
McKinsey
Merck
Harvard Business School

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Haloperidol decanoate - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for haloperidol decanoate and what is the scope of freedom to operate?

Haloperidol decanoate is the generic ingredient in two branded drugs marketed by Janssen Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Mylan Labs Ltd, Sandoz Inc, Somerset Theraps Llc, Teva Pharms Usa, and West-ward Pharms Int, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for haloperidol decanoate. Ten suppliers are listed for this compound.

Drug Prices for haloperidol decanoate

See drug prices for haloperidol decanoate

Drug Sales Revenue Trends for haloperidol decanoate

See drug sales revenues for haloperidol decanoate

Recent Clinical Trials for haloperidol decanoate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Duke UniversityPhase 4
New York State Psychiatric InstitutePhase 4
National Institute of Mental Health (NIMH)Phase 4

See all haloperidol decanoate clinical trials

Pharmacology for haloperidol decanoate
Synonyms for haloperidol decanoate
[4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] decanoate
4-(4-Chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidyl decanoate
74050-97-8
77129-05-6
AC1L1DVL
AC20PJ4101
AKOS025392169
API0024496
BDBM50053408
C31H41ClFNO3
CHEBI:31664
CHEMBL1200986
CTK5D9276
D01898
DECANOIC ACID 4-(4-CHLOROPHENYL)-1-[4-(4-FLUOROPHENYL)-4-OXOBUTYL]-4-PIPERIDINYL ESTER
Decanoic acid, 4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl ester
Decanoic acid, ester with 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
Depot haloperidol
DTXSID50224951
EINECS 277-679-7
FT-0669103
Haldol Dec
Haldol decanoas
Haldol decanoate
Halomonth
Halomonth (TN)
Haloperidol decanoate (JAN/USAN)
Haloperidol decanoate [USAN:BAN:JAN]
Haloperidol decanoate [USAN:USP:BAN:JAN]
Haloperidol Decanoate HCl
Haloperidol depot
KD 136
KD 16
KD-136
KS-1419
LS-59345
MolPort-006-137-967
R 13,672
R 13672
R 13762
R-13,672
R-13672
SCHEMBL120575
UNII-AC20PJ4101
W0040
ZINC8214574

US Patents and Regulatory Information for haloperidol decanoate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gland Pharma Ltd HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 205241-002 May 12, 2017 AO RX No No   Start Trial   Start Trial   Start Trial
Janssen Pharms HALDOL haloperidol decanoate INJECTABLE;INJECTION 018701-002 Jan 31, 1997 AO RX Yes Yes   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 075440-001 Feb 28, 2000 AO RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 074893-001 Dec 19, 1997 AO RX No No   Start Trial   Start Trial   Start Trial
Somerset Theraps Llc HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 209101-001 Jul 3, 2018 AO RX No No   Start Trial   Start Trial   Start Trial
Sandoz Inc HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 076463-002 Jun 24, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 075393-002 May 11, 1999 AO RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Moodys
Mallinckrodt
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.